Skip to main content
Top
Published in: BMC Psychiatry 1/2024

Open Access 01-12-2024 | Schizophrenia | Research

Factors associated with death, hospitalization, resignation, and sick leave from work among patients with schizophrenia in Japan: a nested case–control study using a large claims database

Authors: Ken Inada, Yoshitaka Saito, Kenji Baba, Daisuke Fukui, Yuriko Masuda, Sachie Inoue, Takahiro Masuda

Published in: BMC Psychiatry | Issue 1/2024

Login to get access

Abstract

Background

Premature mortality, frequent relapse that easily leads to hospitalization, and discontinuous employment are key challenges for the treatment of schizophrenia. We evaluated risk factors for important clinical outcomes (death, hospitalization, resignation, and sick leave from work) in patients with schizophrenia in Japan.

Methods

A nested case–control study was conducted for patients with schizophrenia identified in a Japanese claims database. For each outcome, the case was matched with up to four controls of the same age, sex, index year, and enrollment status (employee or dependent family). Potential risk factors were defined by prescriptions or diagnoses within 3 months prior to or in the month of the event. The association among potential risk factors and each outcome was evaluated using multivariable conditional logistic regression analysis with stepwise variable selection.

Results

The number of cases and eligible patients for each outcome were 144 and 38,451 (death), 1,520 and 35,225 (hospitalization), 811 and 18,770 (resignation), and 4,590 and 18,770 (sick leave), respectively. Depression was a risk factor for death (odds ratio [OR]: 1.92; 95% confidence interval [CI]: 1.12, 3.29), hospitalization (OR: 1.22; 95% CI: 1.05, 1.42), and sick leave from work (OR: 1.46; 95% CI: 1.36, 1.57). Other risk factors for death were hospitalization history, Charlson Comorbidity Index (CCI) score, and prescription for laxatives. Prescriptions for hypnotics, laxatives, and anticholinergics were risk factors for hospitalization. Prescriptions for hypnotics and anticholinergics were risk factors for resignation. CCI score, prescription for hypnotics, laxatives, and antidiabetics were risk factors for sick leave from work.

Conclusions

Our findings suggest that depression and some physical symptoms, such as constipation and extrapyramidal symptoms, are risk factors for important clinical outcomes in patients with schizophrenia. Attention should be paid to both depression and physical symptoms for the treatment of schizophrenia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Simeone JC, Ward AJ, Rotella P, Collins J, Windisch R. An evaluation of variation in published estimates of schizophrenia prevalence from 1990 horizontal line 2013: a systematic literature review. BMC Psychiatry. 2015;15:193.CrossRefPubMedPubMedCentral Simeone JC, Ward AJ, Rotella P, Collins J, Windisch R. An evaluation of variation in published estimates of schizophrenia prevalence from 1990 horizontal line 2013: a systematic literature review. BMC Psychiatry. 2015;15:193.CrossRefPubMedPubMedCentral
2.
go back to reference Baba K, Guo W, Chen Y, Nosaka T, Kato T. Burden of schizophrenia among Japanese patients: a cross-sectional National Health and Wellness Survey. BMC Psychiatry. 2022;22(1):410.CrossRefPubMedPubMedCentral Baba K, Guo W, Chen Y, Nosaka T, Kato T. Burden of schizophrenia among Japanese patients: a cross-sectional National Health and Wellness Survey. BMC Psychiatry. 2022;22(1):410.CrossRefPubMedPubMedCentral
3.
go back to reference Hjorthøj C, Stürup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4(4):295–301.CrossRefPubMed Hjorthøj C, Stürup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4(4):295–301.CrossRefPubMed
5.
go back to reference Marwaha S, Johnson S. Schizophrenia and employment - a review. Soc Psychiatry Psychiatr Epidemiol. 2004;39(5):337–49.CrossRefPubMed Marwaha S, Johnson S. Schizophrenia and employment - a review. Soc Psychiatry Psychiatr Epidemiol. 2004;39(5):337–49.CrossRefPubMed
6.
go back to reference Chafi YK, Amare T, Haile K, Damene W, Tesfaye G, Minichil W. Prevalence and correlates of job loss among schizophrenia outpatients at St. AmanuelMental Specialized Hospital, Addis Ababa, Ethiopia; cross sectional study. PLoS One. 2020;15(12):e0242352. Chafi YK, Amare T, Haile K, Damene W, Tesfaye G, Minichil W. Prevalence and correlates of job loss among schizophrenia outpatients at St. AmanuelMental Specialized Hospital, Addis Ababa, Ethiopia; cross sectional study. PLoS One. 2020;15(12):e0242352.
8.
go back to reference Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet. 2012;379(9831):2063–71.CrossRefPubMed Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet. 2012;379(9831):2063–71.CrossRefPubMed
9.
go back to reference Taipale H, Tanskanen A, Mehtälä J, Vattulainen P, Correll CU, Tiihonen J. 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry. 2020;19(1):61–8.CrossRefPubMedPubMedCentral Taipale H, Tanskanen A, Mehtälä J, Vattulainen P, Correll CU, Tiihonen J. 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry. 2020;19(1):61–8.CrossRefPubMedPubMedCentral
10.
go back to reference Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature Mortality Among Adults With Schizophrenia in the United States. JAMA Psychiat. 2015;72(12):1172–81.CrossRef Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature Mortality Among Adults With Schizophrenia in the United States. JAMA Psychiat. 2015;72(12):1172–81.CrossRef
11.
go back to reference Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ. Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry. 2005;187:9–20.CrossRefPubMed Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ. Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry. 2005;187:9–20.CrossRefPubMed
12.
go back to reference Juckel G, Morosini PL. The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia. Curr Opin Psychiatry. 2008;21(6):630–9.CrossRefPubMed Juckel G, Morosini PL. The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia. Curr Opin Psychiatry. 2008;21(6):630–9.CrossRefPubMed
13.
go back to reference Laursen TM, Plana-Ripoll O, Andersen PK, McGrath JJ, Toender A, Nordentoft M, et al. Cause-specific life years lost among persons diagnosed with schizophrenia: Is it getting better or worse? Schizophr Res. 2019;206:284–90.CrossRefPubMed Laursen TM, Plana-Ripoll O, Andersen PK, McGrath JJ, Toender A, Nordentoft M, et al. Cause-specific life years lost among persons diagnosed with schizophrenia: Is it getting better or worse? Schizophr Res. 2019;206:284–90.CrossRefPubMed
14.
go back to reference Siris SG, Addington D, Azorin JM, Falloon IR, Gerlach J, Hirsch SR. Depression in schizophrenia: recognition and management in the USA. Schizophr Res. 2001;47(2–3):185–97.CrossRefPubMed Siris SG, Addington D, Azorin JM, Falloon IR, Gerlach J, Hirsch SR. Depression in schizophrenia: recognition and management in the USA. Schizophr Res. 2001;47(2–3):185–97.CrossRefPubMed
15.
go back to reference Etchecopar-Etchart D, Korchia T, Loundou A, Llorca PM, Auquier P, Lancon C, et al. Comorbid Major Depressive Disorder in Schizophrenia: A Systematic Review and Meta-Analysis. Schizophr Bull. 2021;47(2):298–308.CrossRefPubMed Etchecopar-Etchart D, Korchia T, Loundou A, Llorca PM, Auquier P, Lancon C, et al. Comorbid Major Depressive Disorder in Schizophrenia: A Systematic Review and Meta-Analysis. Schizophr Bull. 2021;47(2):298–308.CrossRefPubMed
17.
go back to reference Conley RR, Ascher-Svanum H, Zhu B, Faries DE, Kinon BJ. The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophr Res. 2007;90(1–3):186–97.CrossRefPubMed Conley RR, Ascher-Svanum H, Zhu B, Faries DE, Kinon BJ. The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophr Res. 2007;90(1–3):186–97.CrossRefPubMed
19.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
20.
go back to reference Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.CrossRefPubMed Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.CrossRefPubMed
22.
go back to reference Miller BJ, McCall WV. Meta-analysis of insomnia, suicide, and psychopathology in schizophrenia. Curr Opin Psychiatry. 2023;36(3):156–65.CrossRefPubMed Miller BJ, McCall WV. Meta-analysis of insomnia, suicide, and psychopathology in schizophrenia. Curr Opin Psychiatry. 2023;36(3):156–65.CrossRefPubMed
23.
go back to reference Japanese Society of Neuropsychopharmacology. Guideline for Pharmacological Therapy of Schizophrenia. Neuropsychopharmacol Rep. 2021;41(3):266–324.CrossRefPubMedCentral Japanese Society of Neuropsychopharmacology. Guideline for Pharmacological Therapy of Schizophrenia. Neuropsychopharmacol Rep. 2021;41(3):266–324.CrossRefPubMedCentral
24.
go back to reference Dollfus S, Ribeyre JM, Petit M. Objective and subjective extrapyramidal side effects in schizophrenia: their relationships with negative and depressive symptoms. Psychopathology. 2000;33(3):125–30.CrossRefPubMed Dollfus S, Ribeyre JM, Petit M. Objective and subjective extrapyramidal side effects in schizophrenia: their relationships with negative and depressive symptoms. Psychopathology. 2000;33(3):125–30.CrossRefPubMed
25.
go back to reference Ballou S, Katon J, Singh P, Rangan V, Lee HN, McMahon C, et al. Chronic Diarrhea and Constipation Are More Common in Depressed Individuals. Clin Gastroenterol Hepatol. 2019;17(13):2696–703.CrossRefPubMedPubMedCentral Ballou S, Katon J, Singh P, Rangan V, Lee HN, McMahon C, et al. Chronic Diarrhea and Constipation Are More Common in Depressed Individuals. Clin Gastroenterol Hepatol. 2019;17(13):2696–703.CrossRefPubMedPubMedCentral
26.
go back to reference Franzen PL, Buysse DJ. Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci. 2008;10(4):473–81.CrossRefPubMedPubMedCentral Franzen PL, Buysse DJ. Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci. 2008;10(4):473–81.CrossRefPubMedPubMedCentral
27.
go back to reference Tsang HW, Leung AY, Chung RC, Bell M, Cheung WM. Review on vocational predictors: a systematic review of predictors of vocational outcomes among individuals with schizophrenia: an update since 1998. Aust N Z J Psychiatry. 2010;44(6):495–504.PubMed Tsang HW, Leung AY, Chung RC, Bell M, Cheung WM. Review on vocational predictors: a systematic review of predictors of vocational outcomes among individuals with schizophrenia: an update since 1998. Aust N Z J Psychiatry. 2010;44(6):495–504.PubMed
28.
go back to reference Schnabel R, Friedel H, Erfurth A, Angermayer M, Clouth J, Eichmann F. Predisposing factors for early retirement in patients with schizophrenia in Germany. Eur J Health Econ. 2008;9(3):265–74.CrossRefPubMed Schnabel R, Friedel H, Erfurth A, Angermayer M, Clouth J, Eichmann F. Predisposing factors for early retirement in patients with schizophrenia in Germany. Eur J Health Econ. 2008;9(3):265–74.CrossRefPubMed
29.
go back to reference Nishiura C, Inoue Y, Kashino I, Nanri A, Endo M, Eguchi M, et al. Diagnosis-specific Cumulative Incidence of Return-to-work, Resignation, and Death Among Long-term Sick-listed Employees: Findings From the Japan Epidemiology Collaboration on Occupational Health Study. J Epidemiol. 2022;32(9):431–7.CrossRefPubMedPubMedCentral Nishiura C, Inoue Y, Kashino I, Nanri A, Endo M, Eguchi M, et al. Diagnosis-specific Cumulative Incidence of Return-to-work, Resignation, and Death Among Long-term Sick-listed Employees: Findings From the Japan Epidemiology Collaboration on Occupational Health Study. J Epidemiol. 2022;32(9):431–7.CrossRefPubMedPubMedCentral
30.
go back to reference Roelen CA, Norder G, Koopmans PC, van Rhenen W, van der Klink JJ, Bültmann U. Employees sick-listed with mental disorders: who returns to work and when? J Occup Rehabil. 2012;22(3):409–17.CrossRefPubMed Roelen CA, Norder G, Koopmans PC, van Rhenen W, van der Klink JJ, Bültmann U. Employees sick-listed with mental disorders: who returns to work and when? J Occup Rehabil. 2012;22(3):409–17.CrossRefPubMed
Metadata
Title
Factors associated with death, hospitalization, resignation, and sick leave from work among patients with schizophrenia in Japan: a nested case–control study using a large claims database
Authors
Ken Inada
Yoshitaka Saito
Kenji Baba
Daisuke Fukui
Yuriko Masuda
Sachie Inoue
Takahiro Masuda
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2024
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-023-05474-5

Other articles of this Issue 1/2024

BMC Psychiatry 1/2024 Go to the issue